Abstract

BACKGROUND
Among alcohol-dependent subjects tobacco smoking is very common and causes a variety of health risks. Therefore, it is necessary to reach this high-risk population early with appropriate smoking interventions.
METHODS
Smokers in alcohol detoxification treatment were offered to participate in a smoking cessation study. A total of 103 patients was enrolled and randomly assigned to either the experimental group (EG) receiving a cognitive behavioral smoking cessation treatment (CBT) or the control group (CG) receiving autogenic training. Smoking outcomes were measured by self-report and carbon monoxide levels, directly after intervention and 6 months later, where additionally alcohol outcomes were recorded.
RESULTS
There were no differences in smoking quit rates directly after intervention. However, patients in the EG were significantly more likely to reduce their daily cigarette use compared to CG (p=.046). Sub-group analyses revealed that heavy smokers (FTND score ≥ 7) seemed to profit most in the EG regarding cigarette reduction. After 6 months, these positive effects had leveled out. No evidence was found that smoking cessation might jeopardize alcohol outcomes.
CONCLUSIONS
Results suggest that alcohol-dependent smokers are interested in smoking interventions even during alcohol detoxification. CBT is promising in short-term smoking outcomes and in the approach of harm reduction, however, long-term effects are desirable. These findings underline the feasibility and the importance to provide smoking cessation interventions to patients in alcohol detoxification treatments.

Links

Publisher Full Text

Authors

Mueller SE, Petitjean SA, Wiesbeck GA

Institution

Division of Substance Use Disorders, Psychiatric Hospital of University of Basel, CH-4012 Basel, Switzerland. Sandra.Mueller@upkbs.ch

Source

Drug and alcohol dependence 126:3 2012 Dec 1 pg 279-85

MeSH

Adult
Alcoholism
Attitude to Health
Cognitive Therapy
Female
Humans
Male
Severity of Illness Index
Smoking
Smoking Cessation
Time Factors
Treatment Outcome

Pub Type(s)

Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

22726914